Actiq Side Effects
Generic name: fentanyl
Note: This document contains side effect information about fentanyl. Some of the dosage forms listed on this page may not apply to the brand name Actiq.
Some side effects of Actiq may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to fentanyl: sublingual spray, sublingual tablet
Other dosage forms:
Get emergency medical help if you have any of these signs of an allergic reaction while taking fentanyl (the active ingredient contained in Actiq) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using fentanyl and call your doctor at once if you have a serious side effect such as:
-
slow heart rate, weak or shallow breathing, sighing, severe drowsiness;
-
confusion, extreme fear, unusual thoughts or behavior; or
-
feeling like you might pass out.
Less serious side effects of fentanyl may include:
-
dry mouth, nausea, vomiting, constipation;
-
headache, drowsiness, tired feeling; or
-
white patches or sores inside your mouth or on your lips.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to fentanyl: buccal film, buccal tablet, compounding powder, injectable solution, nasal spray, oral lozenge, oral transmucosal lozenge, sublingual spray, sublingual tablet, transdermal device, transdermal film extended release
Nervous system
Nervous system side effects have included mental and respiratory depression (particularly in the elderly), stupor, delirium, somnolence, and dysphoria. Muscle rigidity (involving the respiratory musculature including the glottis) may also occur and further aggravate the respiratory depression associated with fentanyl (the active ingredient contained in Actiq) therapy. Myoclonus has been reported with the use of transdermal therapy. A case of severe hemiplegic migraine attack precipitated by fentayl sedation has also been reported.
Cases of seizures have occasionally been reported, but some investigators have suggested that the seizure-like events reported may have been episodes of fentanyl induced-rigidity.
Other
Fentanyl shares the potential for abuse associated with other narcotic analgesics. Cases of inhalation of the contents of fentanyl (the active ingredient contained in Actiq) patches and oral ingestion of intravenous preparations have been reported.
Other side effects have included withdrawal symptoms (agitation, restlessness, anxiety, insomnia, tremor, abdominal cramps, blurred vision, vomiting, and sweating) after either abrupt cessation or fast tapering of narcotic analgesics.
Cardiovascular
Cardiovascular side effects have included hypotension, bradycardia, and arrhythmias rarely.
One report has suggested that epidural fentanyl may mask the pain of myocardial ischemia in patients treated with fentanyl for other reasons. Another report has suggested that QTc interval prolongation may occur in some patients receiving the related narcotic sufentanil. Another report has implicated fentanyl as a potential cause of pulsus alternans in a patient with aortic stenosis and congestive heart failure.
Nevertheless, fentanyl has been advocated by some as a satisfactory agent for coronary artery surgery.
Gastrointestinal
Gastrointestinal side effects including nausea, vomiting, and constipation have been reported to have occurred commonly. Dental decay of varying severity including dental caries, tooth loss, and gum line erosion have been reported. Choledochoduodenal sphincter spasm has been reported rarely.
Respiratory
Respiratory side effects have included respiratory depression which has been frequently observed with fentanyl (the active ingredient contained in Actiq) therapy and one case of acute noncardiogenic pulmonary edema. Coughing has been reported following fentanyl administration for anesthesia induction.
Genitourinary
Genitourinary side effects including urinary retention have been reported for other narcotic analgesics. A case of priapism has been associated with fentanyl (the active ingredient contained in Actiq) anesthesia.
Dermatologic
Dermatologic side effects have included pruritus which has been reported frequently. Localized rashes (associated with the use of transdermal fentanyl (the active ingredient contained in Actiq) patches) and, less commonly, systemic rashes have also been reported.
Hypersensitivity
Hypersensitivity side effects including anaphylaxis have been reported rarely.
Hematologic
The hemolysis observed may have been related to rapid injection of large volumes of hypotonic fentanyl (the active ingredient contained in Actiq) solution. The authors therefore recommend slower injection rates and/or mixture in isotonic fluid.
Hematologic side effects have included one study which suggested that a small amount of hemolysis (of uncertain clinical significance) may occur in patients treated with fentanyl.
Immunologic
Immunologic side effects including a case of recurrent herpes simplex infection have been reported following epidural administration of fentanyl (the active ingredient contained in Actiq) Intravenous fentanyl has been reported to increase natural killer cell cytotoxicity and circulating CD16+ lymphocyte levels.
Metabolic
Metabolic side effects including a case of syndrome of inappropriate antidiuretic hormone have been reported.
More Actiq resources
- Actiq lozenge MedFacts Consumer Leaflet (Wolters Kluwer)
- Actiq Advanced Consumer (Micromedex) - Includes Dosage Information
- Actiq Prescribing Information (FDA)
- Actiq Consumer Overview
- Abstral Consumer Overview
- Abstral MedFacts Consumer Leaflet (Wolters Kluwer)
- Duragesic Advanced Consumer (Micromedex) - Includes Dosage Information
- Duragesic Prescribing Information (FDA)
- Duragesic patch MedFacts Consumer Leaflet (Wolters Kluwer)
- Duragesic Consumer Overview
- Fentanyl Professional Patient Advice (Wolters Kluwer)
- Fentanyl Citrate Monograph (AHFS DI)
- Fentora Consumer Overview
- Fentora MedFacts Consumer Leaflet (Wolters Kluwer)
- Fentora Prescribing Information (FDA)
- Ionsys Consumer Overview
- Ionsys Prescribing Information (FDA)
- Lazanda spray MedFacts Consumer Leaflet (Wolters Kluwer)
- Lazanda Advanced Consumer (Micromedex) - Includes Dosage Information
- Lazanda Consumer Overview
- Onsolis Prescribing Information (FDA)
- Onsolis soluble film MedFacts Consumer Leaflet (Wolters Kluwer)
- Onsolis Consumer Overview
- Sublimaze Prescribing Information (FDA)
- Sublimaze Advanced Consumer (Micromedex) - Includes Dosage Information
- Subsys Prescribing Information (FDA)
- Subsys Consumer Overview
- Subsys spray MedFacts Consumer Leaflet (Wolters Kluwer)
- fentanyl MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


